The Joint Corp. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Accounting Policies [Abstract]

Schedule of Franchisor Disclosure [Table Text Block]

		Three Months Ended September 30,								Nine Months Ended September 30,
Franchised clinics:		2015				2014				2015				2014
Clinics open at beginning of period			239				215				242				175
Opened during the period			13				16				36				57
Acquired during the period			(2	)			-				(23	)			-
Closed during the period			(2	)			(1	)			(7	)			(2	)
Clinics in operation at the end of the period			248				230				248				230

		Three Months Ended September 30,								Nine Months Ended September 30,
Company-owned or managed clinics:		2015				2014				2015				2014
Clinics open at beginning of period			23				-				4				-
Opened during the period			4				-				4				-
Acquired during the period			2				-				23				-
Closed during the period			-				-				(2	)			-
Clinics in operation at the end of the period			29				-				29				-

Total clinics in operation at the end of the period			277				230				277				230

Clinic licenses sold but not yet developed			180				248				180				248

		Year Ended December 31,
		2014				2013
Clinics open at beginning of period			175				82
Clinics opened during the period			73				93
Clinics closed during the period			(2	)			-
Clinics in operation at the end of the period			246				175

Clinics sold but not yet operational			268				223

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended September 30,								Nine Months Ended September 30,
		2015				2014				2015				2014

Net income (loss)		$	(1,656,722	)		$	(202,373	)		$	(5,416,317	)		$	(464,019	)

Weighted average common shares outstanding - basic			9,844,964				4,828,122				9,777,119				4,819,861
Effect of dilutive securities:
Stock options			-				-				-				-
Weighted average common shares outstanding - diluted			9,844,964				4,828,122				9,777,119				4,819,861

Basic and diluted loss per share		$	(0.17	)		$	(0.04	)		$	(0.55	)		$	(0.10	)

		Year Ended December 31,
		2014				2013

Net income (loss)		$	(3,031,220	)		$	155,635

Weighted average common shares outstanding - basic			5,451,851				5,313,665
Effect of dilutive securities:
Stock options			-				21,732
Shares issuable on conversion of preferred stock			-				1,335,000
Weighted average common shares outstanding - diluted			5,451,851				6,670,397

Basic earnings per share		$	(0.56	)		$	0.03
Diluted earnings per share		$	(0.56	)		$	0.02

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		Three Months Ended September 30,								Nine Months Ended September 30,
		2015				2014				2015				2014
Unvested restricted stock			393,339				542,354				393,339				542,354
Stock options			524,600				266,555				524,600				266,555
Warrants			90,000				-				90,000				-

		Year Ended December 31,
		2014				2013
Unvested restricted stock			590,873				-
Stock options			312,995				-
Warrants			90,000				-